<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The receptor tyrosine kinase ROR1 has been shown to be overexpressed in <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (CLL) </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to further characterize the expression of ROR1 and the other member of the ROR family, ROR2, in other lymphoid and <z:e sem="disease" ids="C0027022" disease_type="Neoplastic Process" abbrv="MPD">myeloid malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> white blood cells and reactive lymph nodes were negative for ROR1 and ROR2 </plain></SENT>
<SENT sid="3" pm="."><plain>A significantly high and uniform surface expression of ROR1 was found in CLL/hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> (HCL) compared to mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>), marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MZL</z:e>), diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL), <z:mp ids='MP_0009440'>myelomas</z:mp>, <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) and myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo> (p = 0.02 to &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>The lowest proportion of ROR1+ cells was seen in FL, whereas CLL, HCL and <z:mp ids='MP_0005481'>CML</z:mp> had significantly higher numbers of ROR1+ cells </plain></SENT>
<SENT sid="5" pm="."><plain>Longitudinal follow-up of individual patients with CLL revealed that ROR1+ cells remained stable over time in non-progressive patients, but increased when the disease progressed (p &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Thus, a variable staining pattern of ROR1 ranging from very high (CLL, HCL) and high (<z:mp ids='MP_0005481'>CML</z:mp>) to intermediate (<z:mp ids='MP_0009440'>myeloma</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) or low (FL) was noted </plain></SENT>
<SENT sid="7" pm="."><plain>ROR2 was not detected in <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> </plain></SENT>
</text></document>